| Ticker | STRO |
|---|---|
| ISIN | US8693672011 |
| Sector | Tecnología |
| Mercado | NASDAQ |
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-drug conjugate (ADC) directed against the cancer target CD74 for patients with multiple myeloma and non-Hodgkin lymphoma that is in Phase 1 clinical tri...
El precio actual de Sutro Biopharma, Inc (STRO) es de 33,33 , con una variación del -4,31%.
Sutro Biopharma, Inc opera en el sector Healthcare, industria Biotechnology.